Longevity Biomarkers Move From Wellness Trend to Precision Medicine: Experts Chart the Future of Proactive Health
核心洞察
Longevity medicine is shifting focus from treating disease to maximizing health span, with comprehensive biomarker panels now measuring over 100 indicators from blood, urine, saliva, and performance testing.
Key emerging biomarkers include ApoB for cardiovascular risk, hs-CRP for systemic inflammation, and VO₂ max as a functional predictor of longevity, according to experts Mohammed Enayat, Mark Hyman, and Olga Donica.
Experts recommend biomarker assessments starting in the mid-30s, or earlier for those with family history of cardiovascular disease (搜索), diabetes, cancer, or autoimmune conditions.
The global wellness industry is projected to surpass $2 trillion in 2025, according to McKinsey & Co. (搜索), yet the conversation has decisively shifted from simply being well to staying well for longer. As longevity emerges as one of 2026's leading trends, biomarker testing is rapidly evolving from a niche wellness offering into a sophisticated precision medicine tool—one that experts argue could fundamentally reshape how we approach disease prevention.
"Biomarkers turn health from guesswork into precision and from reactive medicine into truly proactive care," says physician Mark Hyman. "For decades, I watched patients be told they were 'normal' while they were clearly unwell. When we started looking deeper at biomarkers, we could see problems years before the disease showed up on a diagnosis code."
What Are Biomarkers and How Are They Measured?
Mohammed Enayat, a general practitioner, longevity expert, and founder of the HUM2N clinic (搜索), defines biomarkers as "measurable signs in the body that give information about how your body and its systems are functioning." These can include molecules in the blood, hormones, inflammatory markers, fitness metrics, body composition, and sleep quality.
While familiar biomarkers such as blood pressure, heart rate, and vitamin D levels have long been part of routine clinical practice, specialist longevity assessments now measure upward of 100 biomarkers. Samples are collected via blood, urine, saliva, or stool, supplemented by imaging and performance testing. The guiding philosophy, Enayat explains, is "maximizing health span, not treating disease once it appears."
The Rising Stars: ApoB, hs-CRP, and IgG Glycans
Among the most significant markers gaining attention are apolipoproteins, specifically ApoB. "Rather than looking only at cholesterol, we now focus on ApoB, which represents the number of atherogenic particles that can damage arteries," Enayat explains. "Elevated ApoB is strongly linked to cardiovascular disease (搜索), the number one cause of death globally."
Another marker drawing increased focus is high-sensitivity C-reactive protein (hs-CRP) (搜索), which measures systemic inflammation. "This is a core driver of many age-related diseases, including heart disease, cancer, and neurodegeneration," Enayat continues. "Lower hs-CRP is generally associated with better long-term health."
Olga Donica, director of longevity at Clinique La Prairie (搜索), highlights the emerging value of IgG glycan testing. "Glycans are chains of sugars that attach to the surfaces of the cells," she says. "One of the cells they attach to is immunoglobulin G (IgG) (搜索), which is one of the most important antibodies that we have. The structure of the glycans modifies the function of IgG, and its profile can be predictive of different health problems, such as cardiometabolic or autoimmune disorders."
VO₂ Max: A Functional Window Into Longevity
Beyond blood-based markers, both Enayat and Donica emphasize the importance of cardiorespiratory fitness testing, particularly VO₂ max. "This is a great functional biomarker of longevity because it reflects how well the heart, lungs, blood vessels, and muscles work together to deliver and use oxygen," Donica says. "It is more systemic than other biomarkers that reflect the status of a single body function or pathway, and strong evidence from longitudinal studies shows that having a high cardiorespiratory fitness is a powerful predictor of longevity."
From Data to Actionable Insight
Because most biomarkers are influenced by lifestyle, diet, and environment, the resulting data can inform deeply personalized interventions ranging from nutrition and exercise adjustments to advanced medical protocols. As Enayat puts it, "genetics load the gun, but lifestyle often pulls the trigger."
Donica adds that "used well, biomarker testing can make your health capital more tangible and help you adjust your longevity strategy based on actual data." As testing technology becomes more accessible and interpretation more sophisticated, annual screening is increasingly being encouraged.
When Should Testing Begin?
Enayat offers clear guidance on timing: "In my view, anyone who cares about their future health, not just people who are already unwell, should consider a thorough biomarker assessment from their mid-30s onwards, and even earlier if there is a strong family history of cardiovascular disease (搜索), diabetes, cancer, or autoimmune conditions." He underscores the urgency: "Waiting for symptoms is too late. Longevity medicine and biomarker testing are about detecting subtle shifts long before they become disease."
Tools, Not Verdicts
Despite the growing enthusiasm, experts caution against over-interpretation of any single result. "Biomarkers are tools, not verdicts," Enayat reminds. "Numbers should not scare people; they should empower them. No single biomarker tells the whole story. Longevity medicine is about patterns and putting together the puzzle pieces to discover how multiple markers, your genetics, lifestyle, and lived experience interact."
For healthcare professionals and patients alike, the message is clear: biomarkers are quickly becoming one of the most powerful tools available—not to chase perfection, but to steward future health through data-driven, proactive care.